Holly Walsh
About Holly Walsh
Holly Walsh is a Key Account Manager at Amylyx Pharmaceuticals, where she has worked since 2022 in Houston, Texas. She has over a decade of experience in the pharmaceutical industry, specializing in neurology and patient assistance programs.
Work at Amylyx Pharmaceuticals
Holly Walsh has been serving as a Key Account Manager at Amylyx Pharmaceuticals since 2022. Based in Houston, Texas, she plays a crucial role in managing key accounts and fostering relationships within the pharmaceutical industry. Her responsibilities include ensuring effective communication and collaboration with healthcare providers and stakeholders to support the company's objectives.
Previous Experience in Pharmaceuticals
Before joining Amylyx Pharmaceuticals, Holly Walsh held several positions in the pharmaceutical sector. She worked as a Key Account Manager - Neurology at EMD Serono, Inc. from 2012 to 2014. Following that, she served as a Neuroscience Area Manager at Avanir Pharmaceuticals from 2014 to 2017. Additionally, she was a NeuroPsych Account Specialist at Neurocrine Biosciences from 2017 to 2021 and worked in Medical Device Sales - Neuromodulation at Nevro for a brief period in 2021-2022.
Education and Expertise
Holly Walsh earned her Bachelor of Arts degree in Advertising with a minor in Mass Communication from Sam Houston State University, completing her studies from 1998 to 2002. Her educational background supports her professional expertise in managing patient assistance programs, navigating managed care access, and facilitating hub operations within the pharmaceutical industry.
Specialized Skills in Patient Care
Holly Walsh has extensive experience working with specialty pharmacies to ensure product fulfillment. She employs a patient-centric approach in product launches and marketplace growth. Her proficiency in managing patient assistance programs and navigating reimbursement processes enhances her effectiveness in the pharmaceutical landscape.
Connections with Academic Institutions
Holly Walsh has developed significant experience collaborating with academic institutions in the Texas Medical Center. This involvement has allowed her to build networks and enhance her understanding of the healthcare ecosystem, further contributing to her role in the pharmaceutical industry.